Structural characterization and aging of glassy pharmaceuticals made using acoustic levitation

Journal of Pharmaceutical Sciences

Volumn 102, Issue 4, 2013, Pages 1290-1300

  Benmore, Chris J ^a,b   Weber, J K R ^a   Tailor, Amit N ^a   Cherry, Brian R ^b   Yarger, Jeffery L ^b   Mou, Qiushi ^b   Weber, Warner ^b   Neuefeind, Joerg ^c   Byrn, Stephen R ^d  

^a ARGONNE NATIONAL LABORATORY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c OAK RIDGE NATIONAL LABORATORY   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Glass; Glass transition; materials science; NMR spectroscopy; Structure; X ray powder diffractometry

Indexed keywords

CARBAMAZEPINE; CARBON 13; CINNARIZINE; CLOTRIMAZOLE; MICONAZOLE NITRATE; PROBUCOL;

ACOUSTIC LEVITATION; AMORPHIZATION; ARTICLE; ATOM; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL BOND; CHEMICAL REACTION; CRYSTAL STRUCTURE; DRUG FORMULATION; X RAY DIFFRACTION;

EID: 84874672341     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23464     Document Type: Article

References (45)

1. Yu L. 2001. Amorphous pharmaceutical solids: Preparation, characterization, and stabilization. Adv Drug Deliv Rev 48(1):27-42.
2. Willart JF, Descamps M. 2008. Solid state amorphization of pharmaceuticals. Mol Pharm 5(6):905-920.
3. Lu J, Rohani S. 2009. Polymorphism and crystallization of active pharmaceutical ingredients (APIs). Curr Med Chem 16(7):884-905.
4. Kawakami K. 2009. Current status of amorphous formulation and other special dosage forms as formulations for early clinical phases. J Pharm Sci 98(9):2875-2885.
5. Savolainen M, Kogermann K, Heinz A, Aaltonen J, Peltonen L, Strachan C, Yliruusi J. 2009. Better understanding of dissolution behavior of amorphous drugs by in situ solid-state analysis using Raman spectroscopy. Eur J Pharm Biopharm 71(1):71-79.
6. Benmore CJ, Weber JKR. 2011. Amorphization of molecular liquids of pharmaceutical drugs by acoustic levitation. Phys Rev X 1(1):1-7.
7. Capote FP, de Castro MDL. 2007. Techniques and instrumentation in analytical chemistry, analytical applications of ultrasound. Vol. 26. Amsterdam, The Netherlands: Elsevier, pp 268-275.
8. Rindone GR. 1982. Materials processing in the reduced gravity environment of space. MRS Symp Proc. Vol. 9. New York, New York: Elsevier.
9. Barmatz M, Collas P. 1985. Acoustic radiation potential on sphere in a plane, and spherical standing wave fields. J Acoust Soc Am 77(3):928-945.
10. Whymark RR. 1975. Acoustic field positioning for containerless processing. Ultrasonics 13(6):251-261.
11. Rey CA, Merkley DR, Hammarlund GR, Danley TJ. 1987. Acoustic levitation at high temperatures in the microgravity of space. J Acoust Soc Am 82(1):S106.
12. Trinh EH. 1985. Compact acoustic levitation device for studies in fluid dynamics and material science in the laboratory and microgravity Rev Sci Instrum 56(11):2059-2065.
13. Lierke EG, Grossenbach R, Flogel K, Clancy P. 1983. In IEEE Proc. Ultrasonics; McAvoy BR, Ed. Vol. 2. New York: IEEE, pp 1130-1139.
14. Xie WJ, Wei B. 2001. Parametric study of single-axis acoustic levitation. Appl Phys Lett 79(6):881-883.
15. Weber JKR, Rey CA, Neuefeind J, Benmore CJ. 2009. Acoustic levitator for structure measurements on low temperature liquid droplets. Rev Sci Instrum 80(8):083904.
16. Leiterer J, Delissen F, Emmerling F, Thunemann AF, Panne U. 2008. Structure analysis using acoustically levitated droplets. Anal Bioanal Chem 391(4):1221-1228.
17. Baird JA, Van Eerdenbrugh B, Taylor LS. 2010. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci 99(9):3787-3806.
18. Berendt RT, Sperger DM, Munson EJ, Isbester PK. 2006. Solid-state NMR spectroscopy in pharmaceutical research and analysis. Trend Anal Chem 25(10):977-984.
19. Hammersley AP, Svensson SO, Hanfland M, Fitch AN, Hausermann D. 1996. Two-dimensional detector software: From real detector to idealised image or two-theta scan. High Press Res 14(4):235-248.
20. Qiu XY, Thompson JW, Billinge SJL. 2004. PDFgetX2: A GUI-driven program to obtain the pair distribution function from X-ray powder diffraction data. J Appl Crystallogr 37(4):678.
21. Neuefeind J, Feygenson M, Carruth J, Hoffmann R, Chipley K. 2012. The nanoscale ordered materials diffractometer NOMAD at the spallation neutron source SNS. Nucl Instrum Methods B 287:68-75.
22. Paalman HH, Pings CJ. 1962. Numerical evaluation of X-ray absorption factors for cylindrical samples from annular sample cells. J Appl Phys 33(8):2635-2639.
23. Narten AH, Levy HA. 1971. Liquid water: Molecular correlation functions from X-ray diffraction. J Chem Phys 55(1):263-267.
24. Narten AH. 1977. X-ray diffraction pattern and models of liquid benzene. J Chem Phys 67(5):2102-2108.
25. Narten AH, Habenschuss A. 1984. Hydrogen bonding in liquid methanol and ethanol determined by X-ray diffraction. J Chem Phys 80(7):3387-3391.
26. 2 at 25C. J Chem Phys 56(5):1905-1909.
27. Nasr S, Bellissent-Funel M-C, Cortes R. 1999. X-ray and neutron scattering studies of formic acid DCOOD at various temperatures and under pressure. J Chem Phys 110(22):10945-10952.
28. Egelstaff PA, Page DI, Powles JG. 1971. Orientational correlations in molecular liquids by neutron scattering carbon tetrachloride and germanium tetrabromide. Mol Phys 20(5):881-894.
29. Walford G. Dore JC. 1977. Neutron-diffraction studies of the structure of water. Mol Phys 34(1):21-32.
30. Keen DA. 2001. A comparison of various commonly used correlation functions for describing total scattering. J Appl Crystallogr 34(2):172-177.
31. Baird JA, Santiago-Quinonez D, Rinaldi C, Taylor LS. 2012. Role of viscosity in influencing the glass-forming ability of organic molecules from the undercooled melt state. Pharm Res 29(1):271-284.
32. http://www.drugbank.ca
33. Sears VF. 1992. Neutron scattering lengths and cross sections. Neutron News 3(3):26-37.
34. Waasmaier D, Kirfel A. 1995. New analytical scattering-factor functions for free atoms and ions. Acta Crystallogr A 51(3):416-431.
35. Lorch EA. 1969. Neutron diffraction by germania, silica, and radiation-damaged silica glasses. J Phys C 2(2):229-237.
36. Grzesiak AI, Meidong L, Kim K, Matzger AJ. 2003. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci 92(11):2260-2271.
37. Harris RK, Ghi R, Puschmann H, Apperley DC, Griesser UJ, Hammond RB, Ma C, Roberts KJ, Pearce GJ, Yates JR, Pickard CJ. 2005. Structural studies of the polymorphs of carbemazepine, its dihydrate, and two solvates. Org Proc Res Dev 9(6):902-910.
38. 2O) in a mixture by solid-state nuclear magnetic resonance (NMR). Pharm Res 7(2):184-187.
39. McMahn LE, Timmins P, Williams AC, York P. 1996. Characterization of dihydrates prepared from carbemazepine polymorphs. J Pharm Sci 85(10):1064-1069.
40. Mouille PY, Cotrait M, Hospital M, Marsau P. 1975. trans-Cinnamyl-1 diphenylmethyl-4 piperazine (cinnarizine). Acta Crystallogr B 31(5):1495-1496.
41. Peeters OM, Blaton NM, Aeschlimann C, Gal J. (+)-1-[(2S)-2-(2, 4-dichlorophenyl)-2-[(2, 4-dichlorophenyl)methoxy]ethyl]-1H-imidazole mononitrate [(+)-(S)-miconazole nitrate]. Acta Crystallogr E 60(3):365-366.
42. Song H, Shin H-S. 1998. The antifungal drug clotrimazole. Acta Crystallogr C 54(11):1675-1677.
43. Fukami T, Ishii T, Io T, Suzuki N, Yamamoto K, Xu J, Ramamoorthy A, Tomono K. 2009. Nanoparticle processing in the solid state dramatically increases the cell membrane permeation of a cholesterol-lowering drug, probucol. Mol Pharm 6(3):1029-1035.
44. Gerber JJ, Caira MR, Lotter AP. 1993. Structures of two conformational polymorphs of the cholesterol-lowering drug probucol. J Crystallogr Spectrosc Res 23(11):863-869.
45. Pongpeerapat A, Higashi K, Tozuka Y, Moribe K, Yamamoto K. 2006. Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR. Pharm Res 23(11):2566-2574.